The initial public offering (IPO) of Kronox Lab Sciences has garnered significant interest, with a subscription rate of nearly 43 times as of the final day of the bidding process. This surge in subscriptions has been primarily driven by robust demand from non-institutional investors, whose category was oversubscribed by an impressive 113 times.
The categories designated for retail and Qualified Institutional Buyers (QIB) investors were oversubscribed by over 34 times and 4 times, respectively. The IPO reserved 50% for qualified institutional buyers, 15% for non-institutional investors, and the remaining 35% for retail investors.
Comments
Post a Comment